BRD3 Antibodies

Santa Cruz Biotechnology provides a broad selection of BRD3 monoclonal antibodies for research focused on understanding BRD3 protein function. BRD3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BRD3, a member of the bromodomain and extraterminal (BET) family, plays a crucial role in regulating gene expression by interacting with acetylated lysines on histones and non-histone proteins. BRD3 is involved in various cellular processes, including transcriptional regulation, cell cycle progression, and response to stress. Research has shown that BRD3 significantly influences cancer biology, making it an important therapeutic target. Understanding BRD3's molecular mechanisms and cellular functions continues to be a priority in cancer research and drug development. Investigating BRD3's role in normal development and disease progression provides valuable insights into potential therapeutic strategies. Recent studies have highlighted BRD3's involvement in chromatin remodeling and transcriptional activation, expanding our knowledge of epigenetic regulation. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of BRD3's role in human health and disease.